Healthcare AI Acquisition Corp.

Healthcare AI Acquisition Corp. is a special purpose acquisition company (SPAC) formed to complete a merger, share exchange, asset acquisition, or similar business combination with an operating business. It has not yet generated operating revenue and currently earns only interest income on trust-account investments while it searches for a target, with a stated focus implied by its name on healthcare and AI-related opportunities.

0.44

0.44

— Healthcare AI Acquisition Corp.
%
SPAC formation and capital pool100% Public-company shell structure that holds IPO proceeds in trust until a business combination is completed or the company liquidates.
Business combination execution0% Transaction structuring, negotiation, and closing of a merger or similar acquisition with a target operating business.
Administrative and sponsor support0% Minimal corporate administration and sponsor-provided services during the search period.

The company does not sell products or services to end customers in the normal operating sense...

  • Public shareholdersprimary

    Buy the listed shares and warrants for exposure to a future business combination and potential post-merger upside.

  • Sponsor and insidersprimary

    Provide capital, administrative support, and transaction oversight to complete a business combination.

  • Target operating companyprimary

    Would combine with the SPAC to access public markets and capital more quickly than a traditional IPO.

The company is domiciled in the United States and its securities were listed on Nasdaq, but it has no operating revenue...

  • United States domicile and Nasdaq listing
  • No operating revenue or manufacturing footprint yet
  • Potential target search may extend beyond the U.S.
  • Foreign ownership and CFIUS review can affect deal closing
  • Singapore/Cayman-linked counterparty increases cross-border complexity

The core strategy is to complete an initial business combination before the termination date, or else liquidate...

01
Complete an initial business combinationshort-term

The SPAC has no operating business until a transaction closes, so execution is existential.

02
Maintain liquidity and transaction optionalityshort-term

The company needs enough cash to fund search, diligence, and closing costs.

03
Navigate regulatory and listing constraintsshort-term

CFIUS, SEC rules, and Nasdaq compliance can delay or block a deal.

The company faces classic SPAC risks: failure to complete a business combination, forced liquidation, and the...

critical

Failure to complete a business combination before the termination date

The company has no operating business and must liquidate if it cannot close a transaction in time.

Scope
October 14, 2025 termination date
Materiality
high
critical

Investment Company Act classification

If deemed an unregistered investment company, the SPAC may be forced to abandon the deal process and liquidate.

Scope
Trust assets held in short-term securities
Materiality
high
high

Nasdaq delisting and penny-stock designation

Trading suspension and delisting reduce liquidity and can impair the ability to complete a transaction.

Scope
Public shareholders and warrant holders
Materiality
high
high

CFIUS and foreign ownership review

Cross-border directors and counterparties may trigger review, delay, or conditions on a deal.

Scope
Potential U.S. target businesses with sensitive operations
Materiality
medium
Fair value of warrant liability
Reported net income can swing materially quarter to quarter
Trust-account interest income
Declines as redemptions reduce trust balance
Offering costs and temporary equity
Impacts balance sheet classification and early-period results
Going-concern assessment
Material disclosure and liquidation risk

: 28/04/2026